NARI
Income statement / Annual
Last year (2023), Inari Medical, Inc.'s total revenue was $493.63 M,
an increase of 28.73% from the previous year.
In 2023, Inari Medical, Inc.'s net income was -$1.64 M.
See Inari Medical, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$493.63 M
|
$383.47 M
|
$276.98 M
|
$139.67 M
|
$51.13 M
|
$6.83 M
|
| Cost of Revenue |
$64.87 M |
$44.51 M |
$24.76 M |
$13.11 M |
$5.91 M |
$1.28 M |
| Gross Profit |
$428.76 M |
$338.97 M |
$252.23 M |
$126.56 M |
$45.22 M |
$5.55 M |
| Gross Profit Ratio |
0.87 |
0.88 |
0.91 |
0.91 |
0.88 |
0.81 |
| Research and Development
Expenses |
$87.53 M
|
$74.22 M
|
$51.02 M
|
$18.40 M
|
$7.22 M
|
$3.99 M
|
| General & Administrative
Expenses |
$343.66 M
|
$291.89 M
|
$190.02 M
|
$89.41 M
|
$37.20 M
|
$10.70 M
|
| Selling & Marketing
Expenses |
$1.20 M
|
$957,000.00
|
$344,000.00
|
$333,000.00
|
$90,000.00
|
$86.00
|
| Selling, General &
Administrative Expenses |
$344.86 M
|
$292.84 M
|
$190.37 M
|
$89.75 M
|
$37.20 M
|
$10.70 M
|
| Other Expenses |
$2.86 M |
$356,000.00 |
-$18,000.00 |
-$662,000.00 |
-$205,166.00 |
-$133,000.00 |
| Operating Expenses |
$432.40 M |
$367.06 M |
$241.38 M |
$108.15 M |
$44.42 M |
$14.69 M |
| Cost And Expenses |
$497.26 M |
$411.57 M |
$266.14 M |
$121.25 M |
$50.33 M |
$15.97 M |
| Interest Income |
$15.61 M |
$1.85 M |
$154,000.00 |
$484,000.00 |
$89,114.00 |
$92,000.00 |
| Interest Expense |
$196,000.00 |
$294,000.00 |
$295,000.00 |
$1.14 M |
$920,459.00 |
$887,000.00 |
| Depreciation &
Amortization |
$10.75 M
|
$7.64 M
|
$4.53 M
|
$1.49 M
|
$629,520.00
|
$283,048.00
|
| EBITDA |
$7.11 M
|
-$18.77 M
|
$10.98 M
|
$18.24 M
|
$1.30 M
|
-$8.90 M
|
| EBITDA Ratio |
0.01 |
-0.05 |
0.04 |
0.13 |
0.03 |
-1.3 |
| Operating Income Ratio
|
-0.01
|
-0.07
|
0.02
|
0.13
|
0.02
|
-1.34
|
| Total Other
Income/Expenses Net |
$7.88 M
|
$1.91 M
|
$4.01 M
|
-$4.63 M
|
-$1.99 M
|
-$218,000.00
|
| Income Before Tax |
$4.25 M |
-$26.19 M |
$10.69 M |
$13.79 M |
-$1.19 M |
-$10.15 M |
| Income Before Tax Ratio
|
0.01
|
-0.07
|
0.04
|
0.1
|
-0.02
|
-1.49
|
| Income Tax Expense |
$5.88 M |
$3.08 M |
$845,000.00 |
-$912,000.00 |
$715,293.00 |
-$126,000.00 |
| Net Income |
-$1.64 M |
-$29.27 M |
$9.84 M |
$13.79 M |
-$1.91 M |
-$10.15 M |
| Net Income Ratio |
-0 |
-0.08 |
0.04 |
0.1 |
-0.04 |
-1.49 |
| EPS |
-0.0288 |
-0.55 |
0.2 |
0.43 |
-0.0396 |
-0.23 |
| EPS Diluted |
-0.0288 |
-0.55 |
0.18 |
0.27 |
-0.0396 |
-0.23 |
| Weighted Average Shares
Out |
$56.77 M
|
$52.84 M
|
$49.82 M
|
$32.03 M
|
$48.18 M
|
$44.95 M
|
| Weighted Average Shares
Out Diluted |
$56.77 M
|
$52.84 M
|
$55.59 M
|
$51.55 M
|
$48.18 M
|
$44.95 M
|
| Link |
|
|
|
|
|
|
